Marina Stukova

researcher

Marina Stukova is …
instance of (P31):
humanQ5

External links are
P8079elibrary.ru person ID113885
P496ORCID iD0000-0002-2127-3820
P1053ResearcherIDS-4001-2016

P108employerResearch Institute of InfluenzaQ30296245
P735given nameMarinaQ1120708
MarinaQ1120708
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q40691072A genetically adjuvanted influenza B virus vector increases immunogenicity and protective efficacy in mice
Q40350111A novel preservative-free seasonal influenza vaccine safety and immune response study in the frame of preclinical research.
Q39063806Adaptive mutation in nuclear export protein allows stable transgene expression in a chimaeric influenza A virus vector
Q37124744An inactivated, adjuvanted whole virion clade 2.2 H5N1 (A/Chicken/Astana/6/05) influenza vaccine is safe and immunogenic in a single dose in humans.
Q30359013Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine.
Q30382809Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine.
Q30378200Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study.
Q30373298H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers.
Q30382548H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
Q47587998Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults.
Q40246250Influenza virus NS vectors expressing the mycobacterium tuberculosis ESAT-6 protein induce CD4+ Th1 immune response and protect animals against tuberculosis challenge.
Q40069663Safety and immunogenicity of the novel seasonal preservative- and adjuvant-free influenza vaccine: blind, randomized and placebo-controlled trial
Q42373505Targeting an Oncolytic Influenza A Virus to Tumor Tissue by Elastase.
Q83294448Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein